LONGEVITY Welding is Now Offering Tips To Use Welding Machines

Posted on by

HAYWARD, Calif., July 11, 2013 (GLOBE NEWSWIRE) -- via PRWEB - LONGEVITY Global Inc. supplies a huge range of welders and welding machines for a wide variety of welding tasks. This has made them a well-known supplier of all welding equipment in the area. They stock Mig welders, Arc, TIG, Plasma cutters, etc. amongst others for applications ranging from automotive welding, industrial welding and fabrication work. Along with all the products the company is also offering free tips on how to use welding machines and other equipment. They also collaborate and help entrepreneurs set up their welding business. Their welding supplies help their clients bring the cost down and make welding efficient and affordable. Since they have a huge lot of welding equipment, the company also offers certain tips to that would help the users to utilize them to their best.

USING THE CORRECT GUN POSITION AND LAYING DOWN YOUR FIRST BEADS

"You should get familiar with the feel of the gun and familiarize yourself with the effects of changing things like current and wire speed before you try any actual welding. You should start your practice using a common grade of carbon steel like A36, which is the most commonly used steel in manufacturing heavy equipment and readily available as scrap at most industrial equipment manufacturers. Try to find a piece that is about the same thickness as the steel in your work project so that you can get a feel for penetration without blowing holes through the piece. You will also want some thinner and thicker practice pieces as well to experiment with current and wire feed settings." said Simon Katz, President, Longevity Global Inc.

Start with a piece that is about 3.0 mm thick so that the person will not have to worry about blowing holes through the piece if he lingers a little too long at first. Use a surface grinder to remove as much rust and paint from the practice piece as possible and then clean-up the hard to access corner seams using a Longevity cutting tool. Be sure to also clean up an area away from the welding area to attach the ground clamp.

Holding the Gun

Using two hands to keep the gun steady is possible when a person is doing MIG welding. Although one can do MIG welding one handed if he wants, it is best to use both hands to keep a constant space between the work and the tip. Use the free hand to either support the barrel of the welding gun or the wrist of the hand holding the gun. If possible place the work piece on a surface that will allow him to rest his arm on the surface as well. The more consistent everything is during the welding process the better the finished product will be both mechanically and aesthetically.

Setting up the Welder

Many welders will come with a chart attached to the welder cart that will give him a starting point for the current and wire speed based on the material and the thickness of the piece. If One doesn't have a chart he can start with both settings at 50 percent and adjust as necessary until he is comfortable with penetration depth and fill. The person will definitely want to orient the gun to ensure that he has a clear view of the flame and the welding pool as he welds. Set the gun up so that approximately 1/2" of wire is protruding past the shroud.

Starting the Weld

A welder should first tack weld the pieces together so they don't move while he is welding and he can use both hands then to keep the gun movement smooth and steady. The number of tacks he uses should be determined by the length of the weld but one per foot of weld should be adequate. Once he has all set several things needed to be done almost simultaneously to start the continuous weld. First position the welding gun where he wants to start the weld. Then simultaneously pull the trigger and tilt head forward so that the mask and eye protection fall into place. If he prefers he can hold the gun with one hand and use the other to manually position the face mask instead. It really depends only on the welder's personal preference.

Visit link:
LONGEVITY Welding is Now Offering Tips To Use Welding Machines

Professor Antonio Colombo Named to Okyanos Heart Institute’s Medical Advisory Council for Stem Cell Therapy

Posted on by

Freeport, The Bahamas (PRWEB) July 09, 2013

Okyanos Heart Institute, whose mission it is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, has announced that Antonio Colombo, M.D., F.A.C.C. has joined the esteemed group of Okyanos medical advisory council members. Dr. Colombo is director of the Cardiac Catheterization Laboratory at Columbus Hospital and chief of invasive cardiology at San Raffaele Hospital, both in Milan, Italy, and is a visiting professor of medicine at Columbia Medical Center in New York, USA.

Dr. Colombo is a pioneer of the coronary stent placement concept, and he helped define the role of intravascular ultrasound in stent placement. In addition, he was the principal investigator for a cardiac stem cell therapy trial at San Raffaele Hospital, which treated patients with chronic angina.

Okyanos Chief Medical Officer Howard T. Walpole Jr. stated, Dr. Colombo is a leading innovator in cardiology. I welcome his contribution to Okyanos Heart Institutes goal of providing patients the highest standard of safety and care possible with the Okyanos treatment.

The use of adult stem cells derived from adipose (fat) tissue to treat coronary artery disease is an important innovation in cardiovascular care, said Colombo. I am pleased to be able to collaborate with the other members of the Okyanos medical advisory council and Dr. Walpole in bringing this new treatment option to those patients whom we believe it may benefit.

Dr. Colombos research has culminated in multiple publications in some of the most prestigious cardiology journals in the U.S. and Europe. In addition, he is very active in multiple medical societies such as the American College of Cardiology, American Heart Association, and the American College of Physicians. Dr. Colombo is also on the editorial boards of major journals such as Circulation, Journal of the American College of Cardiology, and the American Journal of Cardiovascular Drugs.

We are delighted to have the accomplished Dr. Colombo actively participating in the Okyanos medical advisory council, which already includes thought leaders such as Dr. Eric Duckers, Dr. Farrell Mendelsohn, and Dr. Leslie Miller, says Okyanos CEO Matt Feshbach. Okyanos is committed to bringing together key opinion leaders in cardiology and cardiac stem cell therapy to ensure that patients suffering from chronic coronary artery disease are treated safely and effectively with their own adult stem cells.

About Okyanos Heart Istitue: (Oh key AH nos)

Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.A.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive catheterization, stimulates the growth of new blood vessels, a process known as angiogenesis. The treatment facilitates blood flow in the heart and supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos (Oceanos) symbolizes flow. For more information, go to http://www.okyanos.com/.

Link:
Professor Antonio Colombo Named to Okyanos Heart Institute’s Medical Advisory Council for Stem Cell Therapy

Stem cell therapy: Future of medicine?

Posted on by

by Rappler.com Posted on 07/09/2013 9:42 PM |Updated 07/10/2013 1:18 PM

MANILA, Philippines - Everyone is talking about stem cell therapy. But scammers and swindlers are also taking advantage of the fad, prompting the Health Department to step in. Buena Bernal reports.

Its the new medical buzzword in the Philippines. Stem cell therapy is a procedure which uses repair cells found in the body to replace old cells. Dr Florencio Lucero started doing the procedure 6 years ago.

DR FLORENCIO LUCERO, STEM CELL TRANSPLANT SURGEON: Stem cells can help degenerative diseases. Some people who have serious illnesses, and they cannot find any solution to their condition, they seek this kind of treatment, because it can improve their condition. But not a cure. It cannot cure.

Pilar Vazquez who went through a mild stroke says she felt energized after undergoing the treatment.

PILAR VAZQUEZ, STEM CELL TRANSPLANT PATIENT: Stem cell is very good. I did not feel pain or what. Everything is very good. Before, I dont [always] talk. Now, I always talk. Thats a very good difference, because now they say, Ay si Mommy, ang galing galing niyan, parating nagsasalita!

But stem cell therapy became controversial after 3 government officials allegedly died from the treatment, while another official filed charges against his German doctor for his botched treatment last year. Food and Drug Administration director Dr. Kenneth Hartigan Go says right now, stem cell therapy is allowed but under investigation.

DR KENNETH HARTIGAN-GO, DIRECTOR, FOOD AND DRUG ADMINISTRATION: We are keeping an objective mind and saying, okay, if this is investigational, go ahead. And then we have to see outcome, say, within a period of a time whether the product actually works or not.

The Department of Health cautions the public from engaging in prohibited forms of the treatment -- those that are performed outside accredited facilities and those that source stem cells from human embryos. Health Secretary Enrique Ona says he does not want to stifle the innovation but there must be regulation.

The rest is here:
Stem cell therapy: Future of medicine?

Stem Cell Therapy for Knee Pain: Safer than Surgery

Posted on by

TAMPA, Fla., July 9, 2013 /PRNewswire/ -- Stem Cell Therapy for knee joint pain has been involved in multiple clinical trials worldwide. In the United States trials for knee arthritis and back pain with degenerative disc disease have undergone safety trials and phase studies for effectiveness. The safety profile for stem cell therapy in joints has been proven. Adverse effects are not seen as related to the stem cells. These studies were conducted with allogenic (other people's) stem cells. Naturally, if using your own stem cells, the issues which may be raised from someone else's stem cells is not a concern, and are therefore even safer. There are no immune rejection issues or communicable diseases that can be obtained by using your own cells.

Stem Cell Therapy for joints also do not carry surgical risks such as anesthesia, there is no greater risk for other postoperative complications such as blood clots, infections, or need for revision surgery if it is unsuccessful. Dr. Dennis Lox, a Regenerative and Sports Medicine physician in the Tampa Bay, Florida area (www.drlox.com), comments, "Surgery for joint replacement does carry some significant risks, as this is a highly invasive surgery. Knee and other joint replacement surgery consent forms do include the complication of death. More common problems are infection and blood clots. Stem Cell Therapy injections for joints are no more difficult than injecting cortisone into the knee," states Dr. Lox."There is preparation involved to get to that point, however the injection can be a simple, same-day, office-based procedure."

Dr. Lox notes, "Stem Cell Therapy for joint repair has been used for acute and chronic injuries, knee meniscal tears, loss of knee joint cartilage, and to stop the progression of degenerative arthritis. Even avascular necrosis (AVN) or osteonecrosis has been treated with Stem Cell Therapy. The secondary arthritis from joint collapse in avascular necrosis (AVN) can be significant leading to knee joint replacement. The useof stem cells is becoming a more common alternative to joint replacement."

Dr. Lox further notes, "Some patients may have already had one knee joint replaced with a bad outcome, and wish to avoid a second knee replacement. Others may not be healthy enough. Some medical disorders such as bad hear ailments may preclude having a knee replacement. In these cases, having a regenerative medicine procedure is an attractive, conservative option. Patients who are not medically suited for joint or knee replacement are generally good candidates for Stem Cell Therapy. The pursuit of conservative options in patients who wish to avoid surgery for joint disorders, may find Stem Cell Therapy as an attractive alternative."

About Dr. Dennis Lox Dr. Lox practices in the Tampa Bay Florida area. Dr. Lox is a Sports and Regenerative Medicine Physician, who specializes in the use of regenerative and restorative medicine to assist in treating athletic and arthritis conditions. Dr. Lox may be reached at (727) 462-5582 or visit Drlox.com.

http://www.drlox.com

See the rest here:
Stem Cell Therapy for Knee Pain: Safer than Surgery

H7N9 influenza: History of similar viruses gives cause for concern

Posted on by

Public release date: 9-Jul-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases. David Morens, Jeffery Taubenberger, and Anthony Fauci, in a paper published in mBio, the online open-access journal of the American Society for Microbiology, describe the history of H7 viruses in animal and human disease and point out that H7 influenza has a tendency to become established in bird, horse, and swine populations and may spillover repeatedly into humans.

"The evidence as a whole is complex and the implications of past outbreaks for predicting the future course of the current H7N9 epizootic [an epidemic among animals] are uncertain," write the authors.

The outbreak of H7N9 earlier this year led China to temporarily close scores of live poultry markets in an effort to limit the spread of the virus. Although this previously unrecognized strain of avian influenza A has now been associated with 132 confirmed human infections and 39 related deaths (as of June 14), the rate at which new cases are recognized has dwindled in recent weeks.

In their minireview, Morens, Taubenberger and Fauci point out that despite this apparent hiatus, viruses like H7N9, which have subtype 7 hemagglutinin, are a cause for heightened concern because of several highly unusual characteristics. First, H7 viruses have repeatedly been involved in numerous explosive poultry outbreaks including incidents in New York, Canada, Mexico, the Netherlands, and Italy, and in almost all of these cases the virus eventually spilled over into humans. Also, H7 viruses have the ability to mutate from a low pathogenicity form to a high pathogenicity form in birds, a scenario that can lead to large-scale culling and ultimately to human exposure to the virus among poultry workers.

H7N9 also shares many characteristics with another influenza strain that continues to spillover into humans: highly pathogenic avian influenza H5N1. Among other commonalities, both viruses have a clinical picture that includes bilateral pneumonia, acute respiratory distress syndrome, and multi-organ failure, and it appears they are both currently unable to easily infect most humans but cause severe disease in individuals with uncharacterized genetic susceptibilities.

The fact that many H7 viruses tend to infect conjunctival cells is also cause for concern. Some, but not all, cases of human H7 infection feature prominent signs and symptoms in the eyes, including itching, swelling, and tearing, that could enhance person-to-person spread in an H7N9 outbreak.

The authors point out that many H7 viruses have adapted to infect mammals, including horses and pigs, which raises the possibility that H7N9 could adapt in a similar fashion. The possibility that H7N9 might infect pigs is particularly troubling, as swine are considered a "mixing vessel" for viruses - a breeding ground for novel viral reassortants like the 2009 H1N1 pandemic influenza strain commonly known as "swine flu".

The sum of these observations is this: we do not know what H7N9 will do next. Although avian influenza viruses have not caused widespread human transmission in 94 years of surveillance, there have been numerous instances of avian influenza spillover and H7N9 "might arguably be more likely than other avian viruses to become human-adapted," write the authors.

Excerpt from:
H7N9 influenza: History of similar viruses gives cause for concern

Microbiology Testing: Granular Analysis of the Global Market : Supplier Shares and Forecasts for over 100 Diseases by …

Posted on by

NEW YORK, July 9, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Microbiology Testing: Granular Analysis of the Global Market : Supplier Shares and Forecasts for over 100 Diseases by Country : France, Germany, Italy, Japan, Spain, UK, US http://www.reportlinker.com/p01517631/Microbiology-Testing-Granular-Analysis-of-the-Global-Market--Supplier-Shares-and-Forecasts-for-over-100-Diseases-by-Country--France-Germany-Italy-Japan-Spain-UK-US.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This DataPack contains 800 tables from Venture Planning Group's new 7-country study, 'Global Microbiology Testing Market: US, Europe, Japan'including supplier shares, and forecasts for over 100 tests. This DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global microbiology testing market during the nextfive years, and assist industry executives in developing effective business, new product development and marketing strategies. Geographic Coverage- France - Germany - Italy - Japan - Spain - UK - USAMarket Segmentation Analysis- Sales and market shares of major suppliers of microbiology products, by country and individual assay.- Volume and sales forecasts for over 100 microbiology procedures, by country, individual test and market segment: - Hospitals - Blood Banks - Commercial/Private Laboratories - Physician Offices/Group Practices - Public Health LaboratoriesWorldwide Market Overview- Estimated universe of laboratories performing microbiology tests by country.- Test volume and sales projections by country.Contains 800 tables

List of Tables

Major Companies Developing or Marketing AIDS Tests Major Companies Developing or Marketing Adenovirus Tests Major Companies Developing or Marketing Bartonella Tests Major Companies Developing or Marketing Campylobacter Tests Major Companies Developing or Marketing Candida Tests Major Companies Developing or Marketing Chlamydia Tests Major Companies Developing or Marketing Clostridium Tests Major Companies Developing or Marketing Coronavirus Tests Major Companies Developing or Marketing Cryptosporidium Tests Major Companies Developing or Marketing CMV Tests Major Companies Developing or Marketing Echovirus Tests Major Companies Developing or Marketing Enterovirus Tests Major Companies Developing or Marketing EBV Tests Major Companies Developing or Marketing Giardia Tests Major Companies Developing or Marketing Gonorrhea Tests Major Companies Developing or Marketing Hantavirus Tests Major Companies Developing or Marketing Helicobacter Pylori Tests Major Companies Developing or Marketing Hepatitis Tests Major Companies Developing or Marketing Herpes Tests Major Companies Developing or Marketing Influenza Tests Major Companies Developing or Marketing Legionella Tests Major Companies Developing or Marketing Lyme Disease Tests Major Companies Developing or Marketing Lymphogranuloma Tests Major Companies Developing or Marketing Malaria Tests Major Companies Developing or Marketing Measles Tests Major Companies Developing or Marketing Meningitis Tests Major Companies Developing or Marketing Microsporidium Tests Major Companies Developing or Marketing Mononucleosis Tests Major Companies Developing or Marketing Mumps Tests Major Companies Developing or Marketing Mycoplasma Tests Major Companies Developing or Marketing Papilloma Virus Tests Major Companies Developing or Marketing Parvovirus Tests Major Companies Developing or Marketing Pneumonia Tests Major Companies Developing or Marketing RSV Tests Major Companies Developing or Marketing Rotavirus Tests Major Companies Developing or Marketing Rubella Tests Major Companies Developing or Marketing Salmonella Tests Major Companies Developing or Marketing Septicemia Tests Major Companies Developing or Marketing Shigella Tests Major Companies Developing or Marketing Staphylococci Tests Major Companies Developing or Marketing Streptococci Tests Major Companies Developing or Marketing Syphilis Tests Major Companies Developing or Marketing Toxoplasmosis Tests Major Companies Developing or Marketing Trichomonas Tests Major Companies Developing or Marketing Tuberculosis Tests Major Companies Developing or Marketing West Nile Tests Major Companies Developing or Marketing Yersinia Tests Worldwide All Market Segments Laboratories Performing Infectious Disease Tests by Country Worldwide All Market Segments Total Infectious Disease Test Volume Forecast by Country Worldwide All Market Segments Total Infectious Disease Diagnostics Market Forecast by Country Infectious Disease Tests Major Issues and Market Potential For Personal Testing France Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment France Laboratories Performing Infectious Disease Tests by Market Segment France Hospital Laboratories Performing Infectious Disease Tests by Bed Size France Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume France All Market Segments Infectious Disease Test Volume Forecast France Hospital Laboratories Infectious Disease Test Volume Forecast France Blood Banks Infectious Disease Test Volume Forecast France Commercial/Private Laboratories Infectious Disease Test Volume Forecast France All Market Segments Infectious Disease Diagnostics Market Forecast France Hospital Laboratories Infectious Disease Diagnostics Market Forecast France Blood Banks Infectious Disease Diagnostics Market Forecast France Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast France HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast Forecast by Market Segment France HIV Ag Test Volume and Diagnostics Sales Forecast By Market Segment France Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment France Adenovirus Test Volume and Diagnostics Sales Forecast By Market Segment France Aeromonads Test Volume and Diagnostics Sales Forecast By Market Segment France BEA Test Volume and Diagnostics Sales Forecast by Market Segment France Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment France Campylobacter Test Volume and Diagnostics Sales Forecast By Market Segment France Candida Test Volume and Diagnostics Sales Forecast By Market Segment France Chancroid Test Volume and Diagnostics Sales Forecast By Market Segment France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment France Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment France Coronavirus Test Volume and Diagnostics Sales Forecast By Market Segment France Coxsackievirus Test Volume and Diagnostics Sales Forecast By Market Segment France Cryptosporidium Test Volume and Diagnostics Sales Forecast By Market Segment France CMV Test Volume and Diagnostics Sales Forecast By Market Segment France Cyclospora Test Volume and Diagnostics Sales Forecast By Market Segment France E. Coli Test Volume and Diagnostics Sales Forecast By Market Segment France Echovirus Test Volume and Diagnostics Sales Forecast By Market Segment France Encephalitis Test Volume and Diagnostics Sales Forecast By Market Segment France Enterovirus Test Volume and Diagnostics Sales Forecast By Market Segment France EBV Test Volume and Diagnostics Sales Forecast By Market Segment France Giardia Test Volume and Diagnostics Sales Forecast By Market Segment France Gonorrhea Test Volume and Diagnostics Sales Forecast By Market Segment France Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment France Hantavirus Test Volume and Diagnostics Sales Forecast By Market Segment France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment France HBsAg Test Volume and Diagnostics Sales Forecast By Market Segment France Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment France Anti-HBc Test Volume and Diagnostics Sales Forecast By Market Segment France Anti-HBs Test Volume and Diagnostics Sales Forecast By Market Segment France Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment France Hepatitis Delta Test Volume and Diagnostics Sales Forecast By Market Segment France HAV NAT Test Volume and Diagnostics Sales Forecast By Market Segment France HBV NAT Test Volume and Diagnostics Sales Forecast By Market Segment France HBcAg Test Volume and Diagnostics Sales Forecast By Market Segment France HBeAg Test Volume and Diagnostics Sales Forecast By Market Segment France ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment France Herpes Type VI Test Volume and Diagnostics Sales Forecast By Market Segment

To order this report: In_Vitro_Diagnostic Industry: Microbiology Testing: Granular Analysis of the Global Market : Supplier Shares and Forecasts for over 100 Diseases by Country : France, Germany, Italy, Japan, Spain, UK, US

________________________ Contact Clare: clare@reportlinker.com US:(339) 368 6001 Intl:+1 339 368 6001

Read the original:
Microbiology Testing: Granular Analysis of the Global Market : Supplier Shares and Forecasts for over 100 Diseases by ...

Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. Part 2 – Video

Posted on by


Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. Part 2
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy...

By: Neurogen Brain and Spine Institute

Visit link:
Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. Part 2 - Video

6 things you need to know about stem cell therapy

Posted on by

by Buena Bernal Posted on 07/06/2013 9:06 PM |Updated 07/08/2013 2:15 PM

DOH ON STEM CELL. (Left) Health Secretary Enrique Ona and (right) FDA Director Kenneth Hartigan-Go talks to Rappler about stem cell therapy. Photos by Rappler/Naoki Mengua

MANILA, Philippines (UPDATED) Rappler talked to Department of Health (DOH) Secretary Enrique Ona and Food and Drug Administration (FDA) Director Kenneth Hartigan-Go to clarify the governments stance on stem cell therapy.

Stem cell therapy or regenerative medicine is a medical intervention that uses the bodys repair cells to substitute old cells. It is done for medical and aesthetic purposes that are still being investigated, according to the health secretary.

Asked why the treatment was allowed in the market despite no definitive curative and preventive benefits, FDA's Hartigan-Go said authorities never allowed the treatment to begin with.

Its just there. Now, the DOH under Secretary Ona's leadership took action," he said.

(READ: DOH: Stem cell therapy not yet proven to be curative)

On March 18, the DOH issued the rules and regulations for the accreditation of health facilities engaging in human stem cell and cell-based or cellular therapies in the Philippines.

The FDA has also released a circular on Monday, Jully 8, regarding the guidelines on registering stem cell-based products. The circular covers all products with a "claim, label, or poster" that says stem cells.

(READ: FDA Circular: Registration of Stem Cell-Based Products)

Excerpt from:
6 things you need to know about stem cell therapy

$3-Million Gift Will Advance Dairy Research, Innovation Capacity

Posted on by

July 08, 2013 - News Release

Keeping Ontario and Canada at the forefront of dairy production and health is the goal of a $3 million gift to the University of Guelph from the Dairy Farmers of Ontario (DFO).

It will support both a permanent faculty position in dairy microbiology at the Ontario Agricultural College (OAC) and a research chair in dairy cattle health at the Ontario Veterinary College (OVC). The gift was made through the BetterPlanet Project, the Universitys $200-million fundraising campaign for teaching and research in food, environment, health and communities.

This is a wonderful opportunity for the University and industry, said Rob Gordon, OAC dean. Across our University, there are dozens of professors, researchers and students engaged in dairy-related projects. This will allow us to further strengthen those efforts and support new innovations, as well as build new enthusiasm and excitement around our considerable dairy teaching, service and research.

Elizabeth Stone, OVC dean, said: Were grateful to DFO for its generous support. This gift will help us continue to make major improvements in dairy cattle health and food safety, and to train the scientists and veterinarians who protect the health of our dairy herds.

It will also enhance OVCs ability to recruit highly-qualified graduate students, find solutions to priority concerns confronting the industry, and strengthen collaborations between the University, government and industry, Stone said.

DFO will invest $200,000 a year in each position, with the OVC research chair being supported for five years and the OAC professorship for 10 years. The timing of the new positions coincides with the construction of a $25 million, state-of-the-art, dairy research facility at the U of G-run Elora Research Station; DFO is also committing up to $5 million on behalf of industry stakeholders.

DFO has enjoyed a longstanding relationship with the University of Guelph, and especially with OVC and OAC over the years, said Bill Emmott, chair of the DFO board of directors. We look forward to building on this excellent relationship for the benefit of the dairy producers and the industry we serve.

Peter Gould, DFO general manager and CEO, added that research is critical for the long-term viability of the industry. The areas of innovation, animal care, food safety, and productivity are key research priorities for DFO, he said.

OAC will be conducting a search through the Department of Food Science to fill the new dairy microbiology professorship, Gordon said. The focus will be on dairy microbiology; specifically probiotic and other beneficial microorganisms. This includes validating health benefits, proposing strategies to increase growth and survival of probiotics in dairy products and studying genetic modification to enhance health effects.

More here:
$3-Million Gift Will Advance Dairy Research, Innovation Capacity

Psychology of Longevity Introduction To FoodBoosters – More Energy In Food – Nutrition Health – Video

Posted on by


Psychology of Longevity Introduction To FoodBoosters - More Energy In Food - Nutrition Health
Delivering the best and most advanced information in the world, the Psychology of Longevity introduces you to more information that has to truly grab your attention. These are master secrets...

By: David Cohen

Follow this link:
Psychology of Longevity Introduction To FoodBoosters - More Energy In Food - Nutrition Health - Video

Larry Pithan of KJWW discusses employee longevity and the benefit this provides to clients. – Video

Posted on by


Larry Pithan of KJWW discusses employee longevity and the benefit this provides to clients.
Larry Pithan is Senior Vice President and Secretary-Treasurer of KJWW Engineering Consultants. In this video he discusses the importance of mentoring young engineers, employee longevity and...

By: KJWWConsultants

The rest is here:
Larry Pithan of KJWW discusses employee longevity and the benefit this provides to clients. - Video

The world's places for longevity

Posted on by

How does Dan Buettner stay healthy? For one thing, his job keeps him busy writing and speaking about longevity hot spots.

Buettner, 52, is author of The Blue Zones: 9 Lessons for Living Longer from the People Whove Lived the Longest ($14.95, National Geographic).

It is a one of several books he has written about people whose lifestyles and locales blue zones have kept them alive and kicking longer than most of us.

The essentials of what hes saying are at bluezones.com, the online component of what has become a mini-industry and a mission for Minneapolis-based Buettner. In an interview, he talked about:

What prompted his research: Its a scientific approach to longevity, knowing that only about 20 percent of how long you live is genes; the other 80 percent is lifestyle.

The National Geographics Expeditions Council and the National Institute of Aging wanted me to learn about demographically-confirmed areas where these (long-living) people are. It was a three-year, half-million-dollar project to statistically identify them through birth and death records, etc. Once these pockets of people are identified, you can reverse-engineer the long-life formula, and thats what we set out to do.

It was kind of an uber-assignment for me to research and write.

The point I try to make is that theres no silver bullet no magical vegetable or supplement. We found it was a swarm of silver buckshot that adds up to extraordinary longevity in five places.

The long-living places: There are five places. For women, its the main island of Okinawa, Japan. For men, its the Nuoro highlands of Sardinia. For the best chance of reaching 90 or 95, its the Nicoya Peninsula of Costa Rica. The longest-living Americans are Seventh-day Adventists who are concentrated around Loma Linda, Calif., and the strictest Adventists live about 10 years longer than their counterparts.

The final blue zone is Ikaria, Greece (an island in the Aegean Sea). It is not only among the places for people who live longest, but theres hardly any dementia there. The team that followed up on my work surveyed people there who were

Read more from the original source:
The world's places for longevity